Andere Sprachen Catalent, Inc.

Aktien

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 21.05.2024			% 5 Tage	% 1. Jan.
54,96 ^USD	-0,07 %		-1,01 %	+22,32 %

16.05.	CATALENT, INC. : Herabstufung von Kaufen auf Verkaufen durch Argus	ZM
14.05.	Novo Nordisk verkauft $5 Milliarden in Anleihen zur Unterstützung des Catalent-Deals	MT

Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal	14.05.
Novo Nordisk Plans First Bond Sale in Two Years	14.05.
Novo Nordisk Plans First Bond Sale in 2 Years	13.05.
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	09.05.
Catalent: Fiscal Q3 Earnings Snapshot	09.05.
Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B	08.05.
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results	08.05.
Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	08.05.
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer	08.05.
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	03.05.
Catalent, Novo Nordisk Antitrust Review Extended by FTC	03.05.
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	03.05.
US FTC seeks more information on Novo Nordisk parent-Catalent deal	03.05.
FTC seeks more information on Novo Holdings-Catalent deal	03.05.
Novo Nordisk baja el precio de su medicamento contra la obesidad debido a la competencia	02.05.
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	02.05.
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast	02.05.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ANSS, CTLT	30.04.
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)	18.04.
Sector Update: Health Care Stocks Decline Late Afternoon	08.04.

Keine Ergebnisse zu dieser Suche